We also confirmed that MGMT promoter methylation is an independent prognostic factor of survival in patients with GBM.[9,12] Both PFS and OS were significantly higher in patients with MGMT methylation compared to those without such methylation. The gene discussed is MGMT; the disease is glioblastoma.